论文部分内容阅读
答:陈志康等撰写的《药源性疾病》评介一文中,指出该书102页烯丙吗啡这一名称是错误的、应改为丙烯吗啡,但未说明丙烯基和烯丙基的区别[药学通报1983;18(6):366]。《新编药物学》12版将本品命名为丙烯吗啡。又有人指出:这不符合《中国药典》1985年版所载的烯丙吗啡[药学通报1987;22(5):314]。对同一药
A: An article written by Chen Zhikang et al. On Drug-Induced Diseases states that the title of alflutropide is erroneous on page 102 and should be changed to morphine but not the difference between allyl and allyl [pharmacy Bulletin 1983; 18 (6): 366]. “New Pharmacology” 12 version of the product named propylene morphine. Others point out that this does not correspond to the nalorphine contained in the 1985 edition of the Chinese Pharmacopoeia [Pharmacological Bulletin 1987; 22 (5): 314]. For the same medicine